HEPA

HEPA Hedge Fund & Institutional Holdings

Hepion Pharmaceuticals INC

+$1.4K

Net Activity

Data as of: 2025-06-30

Institutions Holding

Popularity Rank

#14693

Avg Weight

0.00%

Total Value

$1.4K

Ownership Trend

3 institutions currently hold HEPA, with 2 net buyers and 4 net sellers this quarter.

Institutional Moves

Institutional Moves (Q2 2025)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

Net Buying Institutions

Key Holders

Top 5 by Value

Top 5 by Conviction

View all 3 holding institutions

Quarterly Activity

Recent Activity

+$0.0

Total Buy Value

$13.7K

Total Sell Value

New buy1

Trim0

Add1

Sold out4

Net Buyers

Net Sellers

Smart Money Convergence

HEPA does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2025-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/HEPA

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-02

2026-07-02

On July 1, 2026, Hepion Pharmaceuticals appointed Danina Fisher and Gary S. Stetz, II as new directors. Mr. Stetz is the son of Gary Stetz, as noted in the filing. The appointments are effective immediately.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

426897401

FAQ

Who are the top institutional investors holding HEPION PHARMACEUTICALS INC (HEPA)?

Major stakeholders currently include XTX Topco Ltd ($1.4K), Osaic Holdings, INC. ($0.0), Barclays PLC ($0.0). Based on the latest 13F filings, there are a total of 3 tracked investment funds and institutions maintaining positions in HEPA.

What is the overall institutional sentiment toward HEPA recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.4K, driven by 2 managers accumulating shares while 4 reduced their exposure.

Which institutions have been selling or reducing their HEPA positions?

In the latest period, 0 funds trimmed their holdings, and 4 managers completely exited their positions. The aggregate reported sell value was $13.7K.

Are there any notable investors adding HEPA to their portfolios?

Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $0.0.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access HEPA's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/HEPA

CLI

npx alphasmo stocks get HEPA

Full API & MCP documentation →